Together, Precision and ApoCell provide a unique and comprehensive suite of specialty services and translational sciences solutions, from data management and biomarker analytics capabilities to liquid biopsies and tissue profiling.

ApoCell works to integrate today’s leading innovative technologies into one seamless platform technology.

ApoCell can develop biomarker assays to meet your precise validation needs. Our experienced team has developed hundreds of assays using different platforms that have been successfully incorporated into Phase I-III clinical trials. We also have experience in technology transfer to cross-validate assays.

ApoCell is a pioneer in capturing and analyzing Circulating Tumor Cells (CTCs) from patient blood to monitor the pharmacodynamic effects of investigational therapies in clinical trials. We specialize in generating data to assess drug mechanism of action, optimal dosing schedules, resistance biomarkers, and to facilitate patient stratification including companion Dx development.

ApoCell’s molecular profiling services specialize in optimizing sensitivity using low nucleic acid input from circulating free tumor DNA or DNA extracted from rare cells.

ApoCell develops customized solutions for flow cytometry biomarker challenges. Our scientists take a hands-on, collaborative approach to developing and deploying flow cytometry assays that perform to meet your standards.

ApoCell develops state-of-the-art FISH assays to detect abnormalities in both hematological and solid organ tumors. We can help design a custom FISH assay to meet your specific clinical trial needs.

ApoCell utilizes customized immunohistochemistry (IHC) assays for clinical and translational research. Pick from our wide selection of validated markers or let our experienced scientists create a custom assay.

ApoCell specializes in developing high complexity, custom immunofluorescence assays and analyzing images. We have successfully developed hundreds of quantitative immunofluorescence assays for tissue and cytology samples including circulating tumor cells (CTCs).

For an in-depth assessment of inflammatory responses, ApoCell’s cytokine profiling assays are designed to measure cytokines and chemokines released from chosen target cells as a potential biomarkers for efficacy.

ApoCell offers a full range of pathology and sample preparation services for clinical samples 365 days per year.

ApoCell has entered into several strategic alliances with pharmaceutical and biotechnology companies and contract research organizations.